Voluntary Recall of two batches of Dopram100 MG /5ML produced by EUMEDICA PHARMACEUTIC ALS FRANCE Manufacturer
2026-02-12
الاسم التجاري الاسم العلمي رقم التسجيل رقم التشغيلة المتأثرة الشركة الصانعة Trade Name Scientific Name Register Number Affected batch number Manufacturer Dopram 100 MG /5ML DOXAPRAM غير مسجل 50478 50293 EUMEDICA PHARMACEUTIC ALS FRANCE
التصنيف
ملف
التاريخ
2025-11-02
اسم المستحضر
Dopram 100 MG /5ML
اجراء الاستدعاء
مستوى الاستدعاء
نوع المستحضر
سبب السحب
SFDA has issued a recall of two batches of Dopram 100 MG /5ML due to non-compliance with specifications. The company requested voluntary recall of the affected batches.
التوصيات
For healthcare professionals: Stop dispensing the affected batches immediately. Embargo/Quarantine all remaining stock. Affected batches should be returned to the supplier.
For patients,
- Consult your healthcare provider prior to discontinuing use of the affected batches, or for any health concerns.
- Contact the recalling firm or SFDA if you have any questions about the recall.
- Adverse reactions or quality problems experienced with the use of this product may be reported to Saudi Vigilance either online or call center (Call 19999).
Comments and Suggestions
For any inquiries or comments about the government services, please fill in the required information.